"Hyperkalemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)
| Descriptor ID |
D006947
|
| MeSH Number(s) |
C18.452.950.396
|
| Concept/Terms |
Hyperkalemia- Hyperkalemia
- Hyperkalemias
- Hyperpotassemia
- Hyperpotassemias
|
Below are MeSH descriptors whose meaning is more general than "Hyperkalemia".
Below are MeSH descriptors whose meaning is more specific than "Hyperkalemia".
This graph shows the total number of publications written about "Hyperkalemia" by people in this website by year, and whether "Hyperkalemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 2 | 2 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 3 | 0 | 3 |
| 2016 | 2 | 1 | 3 |
| 2017 | 2 | 1 | 3 |
| 2018 | 1 | 2 | 3 |
| 2019 | 6 | 0 | 6 |
| 2020 | 2 | 1 | 3 |
| 2022 | 3 | 0 | 3 |
| 2023 | 4 | 0 | 4 |
| 2024 | 2 | 1 | 3 |
| 2025 | 2 | 0 | 2 |
| 2026 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hyperkalemia" by people in Profiles.
-
Steroidal or non-steroidal MRAs: should we still enable RAASi use through K binders? Nephrol Dial Transplant. 2023 05 31; 38(6):1355-1365.
-
Spironolactone effect on potassium supplementation in paediatric cardiac intensive care patients. J Clin Pharm Ther. 2017 Aug; 42(4):433-437.
-
Reverse pseudohyperkalemia in heparin plasma samples from a patient with chronic lymphocytic leukemia. Clin Biochem. 2011 Jun; 44(8-9):728-30.
-
The status of allopurinol in the management of tumor lysis syndrome: a clinical review. Cancer J. 2005 Jan-Feb; 11 Suppl 1:S1-10.
-
Upper gastrointestinal tract injury in patients receiving kayexalate (sodium polystyrene sulfonate) in sorbitol: clinical, endoscopic, and histopathologic findings. Am J Surg Pathol. 2001 May; 25(5):637-44.
-
H+-ATPase in hyperkalemic distal renal tubular acidosis. Am J Kidney Dis. 1998 Dec; 32(6):1091-5; discussion 1095-7.
-
Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation. Bone Marrow Transplant. 1997 Dec; 20(12):1095-8.
-
Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: an underrecognized condition. Am J Surg Pathol. 1997 Jan; 21(1):60-9.
-
Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine (Baltimore). 1986 May; 65(3):163-72.